Claire OCT System
Perimeter Medical Imaging Ai, Inc. · Decision date Mar 3, 2026
What did the FDA approve?
FDA records P250008 as an original PMA application. The recorded decision is approval, dated Mar 3, 2026.
FDA approval order statement
The Claire OCT System is an adjunctive three-dimensional imaging tool which provides volumetric cross-sectional, real-time depth visualization, coupled with an artificial intelligence computer-aided detection algorithm which identifies and marks focal areas suspicious for breast cancer and is used concurrently with physician interpretation of the images. The Claire OCT System is intended for use in conjunction with other standard methods for evaluation of the margins of excised lumpectomy tissue during surgical procedures in patients with a biopsy-confirmed diagnosis of breast cancer.
- Regulatory pathway
- Original PMA
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Mar 3, 2026
Regulatory record facts
- Identifier
- P250008
- Regulatory pathway
- Premarket approval application
- Applicant
- Perimeter Medical Imaging Ai, Inc.
- Product code
- SHH
- Decision code
- APPR
- Decision date
- Mar 3, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: OCT imaging system with AI/ML software for adjunctive detection of breast cancer.
- Applicant
- Perimeter Medical Imaging Ai, Inc.
- Product code
- SHH
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P250008 received
Application receipt date recorded by FDA.
P250008 · FDA decision
APPR
P250008/S001 · Related supplement
Claire OCT System
Timeline entries are records held by MedtechLedger for P250008. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P250008
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Claire OCT SystemP250008/S001 | Perimeter Medical Imaging Ai, Inc. | PMA supplement | Aug 10, 2026 | FDA |
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Perimeter Medical Imaging Ai, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 555 Richmond St. W, Suite 511, Toronto, M5V 3B1
Sources and methodology
- Original FDA record: P250008
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records